Photo of James H. Wallace, Jr.

Education

J.D., Georgetown University Law Center

B.S.E.E., University of South Carolina; Tau Beta Pi; Eta Kappa Nu; Pi Mu Epsilon

Law Journals

Associate Editor, Georgetown Law Journal

Bar and Court Admissions

District of Columbia Bar

Supreme Court of the United States

U.S. Courts of Appeals for the Fourth, Fifth, Sixth, Eighth, Ninth, Eleventh, Federal, and District of Columbia Circuits

U.S. District Courts for the District of Columbia, Eastern District of Arkansas, Eastern District of Texas, Eastern District of Wisconsin, Northern District of California, Western District of Arkansas, and Western District of Michigan

U.S. Court of Federal Claims

U.S. Court of International Trade

U.S. Patent and Trademark Office

District of Columbia Court of Appeals

Jim is chair emeritus of the Wiley Rein Intellectual Property Group, previously he served as chair for many years. Jim has more than 30 years of experience litigating patents in the fields of communications satellites, data transmission, network interface devices, Internet business methods, pharmaceuticals, biotechnology, and semiconductors. A founding partner of the firm, he was named by Legal Times as a “Leading Intellectual Property Attorney” and recognized as one of the “Best Lawyers in America” in intellectual property law. He also is rated by Chambers USA as one of Washington, DC’s “Leading Lawyers” in his field which notes him as having “significant experience in litigating and trying patent cases, particularly matters concerning technology, communications, biotechnology and pharmaceuticals” (2014) and as being “very professional, very well organized, and on top of everything" (2013).

Representative Experience

  • Secured, on behalf of client NTP Inc., a $612.5 million patent infringement settlement with Research In Motion Ltd. (RIM), the maker of BlackBerry wireless email devices. The settlement, one of the largest ever of its kind, resolved a fiercely contested, high-profile patent case stemming from a 2002 jury trial in which the firm successfully argued that RIM's core BlackBerry line of wireless email products, software and services willfully infringed NTP patents.
  • Litigated numerous pharmaceutical patent cases, including aripiprazole (Abilify®), cetuximab (Erbitux®), loratadine (Claritin®), oxybutynin chloride (Ditropan XL®), carbidopa/levodopa (Sinemet® CR), tamoxifen citrate (Nolvadex®), allopurinol (Zyloprim®), tPA (Activase®), omeprazole (Prilosec®), cyclobenzaprine HCl (Amrix®), erlotinib (Tarceva®), interferon (Roferon®-A), levofloxacin (Levaquin®), dutasteride (Avodart®), fenofibrate (Antara®), and tolterodine tartrate (Detrol® LA).
  • Represented a developer of electronic imaging systems in a patent infringement action against 17 Japanese and Korean manufacturers involving the seeing-eye elements of camcorders and fax machines that convert light into electrons, known as charge coupled device (CCD) technology.
  • Successfully represented clients in 337 patent infringement actions before the U.S. International Trade Commission (USITC), including a case involving novel microwave filters on satellites that, based upon their light weight, enabled increased satellite life.
  • Secured a significant victory for clients Mylan Inc. (formerly Mylan Laboratories Inc.), Mylan Pharmaceuticals Inc., Laboratorios Dr. Esteve, S.A., and Esteve Quimica, S.A. in their defense of a protracted patent infringement litigation brought by AstraZeneca. 
  • Successfully defended Royal Crown Cola in major antitrust challenge to exclusive geographic franchise agreements.
  • On behalf of Royal Crown Cola successfully challenged, under the antitrust law, the proposed Pepsi/Seven Up and Coke/Dr. Pepper mergers.
  • Secured a victory for client ARM Ltd. in defense of claims of patent infringement pertaining to the design of microprocessors. 
  • Filed an amicus brief, on behalf of Nobel Prize winner James D. Watson, in the landmark Myriad Genetics Inc. human gene patent case before the Supreme Court of the United States. 

Professional Experience

  • Trial Attorney, U.S. Department of Justice, Antitrust Division (1967-1970)
  • Patent Examiner, U.S. Patent and Trademark Office (1966-1967)
  • Advisory Board, Bloomberg BNA's Patent, Trademark and Copyright Journal

Affiliations

  • American Bar Association (ABA)

Recognitions

  • Listed by Chambers USA as one of "America's Leading Lawyers for Business" in Intellectual Property: Litigation (2010-2016)
  • Named the Washington, DC Intellectual Property Litigation "Lawyer of the Year" by The Best Lawyers in America directory (2015)
  • Included in The Best Lawyers in America directory for Intellectual Property Litigation (2006-2017) and Patent Litigation (2013-2017)
  • Named a "Life Sciences Star" for outstanding Intellectual Property work in Euromoney's LMG Life Sciences (2012-2015)
  • Named by Lawdragon as one of "500 Leading Lawyers in America" (2008, 2010-2011)
  • Named one of "Washington's Best Lawyers" (2011, 2013), one of "DC's Top 30 Lawyers" (2007), among the city's best IP attorneys (2004, 2007), and one of "Washington's Top Lawyers" (2009) by Washingtonian magazine
  • Named one of DC's "Super Lawyers" for Intellectual Property Litigation by Super Lawyers magazine (2007-2016, Corporate Counsel Edition, August 2008)
  • Included in the Legal Media Group's Expert Guides: Guide to the World's Leading Patent Law Practitioners (2007, 2009)
  • Named one of 15 leading IP attorneys by Legal Times (2003)
  • AV Peer Review Rating, Martindale-Hubbell's highest ranking by peers for general ethical standards and legal ability

News & Insights